Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-05-001873
Filing Date
2005-03-16
Accepted
2005-03-16 17:06:11
Documents
14
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 c36063_10k.txt 10-K 427418
2 c36063_ex10-22.txt EX-10.22 60923
3 c36063_ex10-33.txt EX-10.33 142473
4 c36063_ex10-35.txt EX-10.35 3970
5 c36063_ex10-36.txt EX-10.36 4459
6 c36063_ex10-37.txt EX-10.37 7231
7 c36063_ex10-38.txt EX-10.38 21733
8 c36063_ex10-39.txt EX-10.39 76118
9 c36063_ex21-1.txt EX-21.1 1112
10 c36063_ex23-1.txt EX-23.1 1514
11 c36063_ex31-1.txt EX-31.1 4653
12 c36063_ex31-2.txt EX-31.2 4604
13 c36063_ex32-1.txt EX-32.1 1201
14 c36063_ex32-2.txt EX-32.2 1206
  Complete submission text file 0000930413-05-001873.txt   761286
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16132 | Film No.: 05686347
SIC: 2834 Pharmaceutical Preparations